<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Biochemistry</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/488C2FCA-F5F6-42C3-AA92-60939413CC24"><gtr:id>488C2FCA-F5F6-42C3-AA92-60939413CC24</gtr:id><gtr:firstName>Kathryn</gtr:firstName><gtr:otherNames>Susan</gtr:otherNames><gtr:surname>Lilley</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/486DCA82-567C-4A27-AE24-40C1C65D54AD"><gtr:id>486DCA82-567C-4A27-AE24-40C1C65D54AD</gtr:id><gtr:firstName>Martin</gtr:firstName><gtr:surname>Welch</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FF01581X%2F1"><gtr:id>DF142C25-B87F-4A02-814A-F2A8CF8709C6</gtr:id><gtr:title>Mass spectrometry-based 'omic mining through the biostrata of Pseudomonas aeruginosa colonies and biofilms</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/F01581X/1</gtr:grantReference><gtr:abstractText>Pseudomonas aeruginosa is a Gram-negative opportuinistic human pathogen, which is responsible for causing a wide range of nosocomial infections. However, the organism is perhaps best known for forming antibiotic-insensitive mucoid colonies and biofilms deep within the lungs of patients with cystic fibrosis, and is responsible for causing high rates of morbidity and mortality among this population. Bacterial assemblies such as biofilms have been the subject of intensive investigation over the last few decades. In particular, they have been the focus of numerous functional genomic analyses. However, interpretation of the data derived from these approaches has been hampered by the fact that biofilms and colonies are complex structures which break down upon mechanical intervention. This means that we necessarily lose a lot of information about the spatial distribution of biomolecule expression simply due to the invasive/destructive nature of the sample harvesting procedure. Low through-put approaches like laser scanning confocal fluorescence microscopic analysis of fluorescently-labelled fusion proteins has revealed that biofilms are highly likely to exhibit stratified protein expression. However, until very recently, no high through-put approach could be applied to assess how global biomolecule profiles vary through and across microbial bioassemblies. The potential to investigate this issue directly came recently with the introduction of real-time, spatially-resolved analysis of biological samples in ambient (i.e., 'wet') conditions. The technology required to do this exploits 'DESI' MS, which is based on desorption electrospray ionization. Here, a fine spray of charged solvent droplets is used to 'mine in' to the sample. The resulting desorbed ions are then collected and passed into a mass spectrometer for on-line analysis, and, in the case of proteins, 'top-down' identification. DESI-MS was developed in the lab of Dr Graham Cooks, who has applied the technique to a range of biological samples (including human skin, dried- and liquid blood, plant surfaces, urine samples and even the margins of solid tumours). Work from Cooks' lab has also demonstrated that DESI is effective for both proteomic and metabolomic profiling. However, outside Cooks' lab, DESI has seen very little uptake, partly because the necessary hardware has only recently become available, and partly due to lack of awarness of the technology amongst the wider biological sciences community - especially microbiologists. In this project, we aim to exploit DESI to study how the metabolite and protein expression profiles vary across and through colonies and biofilms of P. aeruginosa. We fully anticipate that this approach will provide information about the global biomolecule profiles of cells growing in different parts of these structures. This approach complements our existing research priorities extremely well, and will add a valauble extra dimension to the capabilities of the BBSRC-funded Cambridge Centre for Proteomics.</gtr:abstractText><gtr:technicalSummary>DESI is a newly developed mass spectrometric technique that enables biological samples to be analysed in situ. The Omni-Spray ion source required for DESI is now commercially-available, and can be attached to existing MS devices made by most major manufacturers. Crucially, operating parameters such as the output power (ES voltage) and composition (solvent) of the electrospray beam can be modulated such that DESI can be used to abrade through biological materials, allowing the user to 'mine down' and access biostrata below the surface of the sample. In addition, by rastering the ES beam across a sample, a lateral profile of biomolecule expression can be measured. DESI was introduced in October 2004 (although the commercial hardware only became available more recently), and so far, most of the studies exploiting it have been proof-of-principle technologies done in the laboratory of the inventor, Dr Graham Cooks. In the current proposal, we aim to use DESI to investigate the latent biostrata comprising bacterial biofilms and colonies. Biofilms have been the subject of many studies exploiting functional genomic analyses, yet in all cases, this has necessarily involved whole-scale mechanical perturbation of the biostructure. Because of this, we still know very little about the true nature of the biostratification in such bacterial assemblages, and it is becoming increasingly clear that this structural differentiation plays a central role in the physiology of these communities. Our existing lab priorities focus on proteomic and metabolomic analyses of Pseudomonas aeruginosa biofilms, colonies and planktonic cells, and we hope that the proposed study will complement this ongoing work. Very few other workers (on any continent) are currently exploiting DESI, so we have a unique window of opportunity in which to develop this approach further, and to exploit it in the investigation of an important microbiological and clinical problem.</gtr:technicalSummary><gtr:fund><gtr:end>2009-12-11</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2008-05-12</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>91331</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Cambridge Centre for Proteomics</gtr:department><gtr:description>Strengthening of collaborations</gtr:description><gtr:id>2ACC92A8-37B4-437E-ADE7-F50D01AF6FB7</gtr:id><gtr:outcomeId>b9629ff8b962a00c-1</gtr:outcomeId><gtr:piContribution>Continuation (from 12-05-2008 to the present day) and strengthening of my ongoing collaborative partnership with Dr David Spring in the Chemistry Dept and Dr Kathryn Lilley (co-applicant) in the Cambridge Centre for Proteomics research. Both ongoing collaborations continue to be active and productive.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Press release</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>4174A1D8-128A-4DF8-A8DD-37142D9042D7</gtr:id><gtr:impact>A press release was made (via the offices of the SGM) reporting on a new biofilm-specific protein (PA2783) that resembled a snake venom toxin. Several local, national and international papers carried reports on this. The results were presented at the Dublin SGM meeting of that year. Press release prepared by the SGM. Newspaper reports (national and international)

no actual impacts realised to date</gtr:impact><gtr:outcomeId>r-53615653.937324560ba3a054</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research or patient groups</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>Basicaly, the &amp;quot;new&amp;quot; technology we were trying to test was not suitable for the task, although the research did yield other dividends along the way.</gtr:description><gtr:id>1AC0BE2A-512D-4438-A886-A2DFD0D810CC</gtr:id><gtr:impactTypes/><gtr:outcomeId>5445087a15d330.68491833</gtr:outcomeId></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>(1), Primarily, we showed that the technology (DESI) does not work as well as the manufacturers say it does. In addition, we have defined a core set of gene products that are exclusively produced by biofilms of P. aeruginosa. GFP fusions have been made to some of these key proteins and we have used laser-scanning confocal microscopy to map their expression profile through biofilms (one objective of the grant).



(2), We have identified a biofilm-specific protein (putative disease biomarker) and have demonstrated that this biomarker is expressed in cystic fibrosis sputum samples (CF sputum is colonised by biofilm-associated P. aeruginosa).</gtr:description><gtr:exploitationPathways>I would not recommend the DESI for investigating bacterial community architecture, although I beleive other members of teh Dept have used it for looking at metabolic differences when scanning across e.g., diseased/healthy tissue types, tumour boundaries etc.</gtr:exploitationPathways><gtr:id>912AB750-4EDB-4715-9038-87557F732B1D</gtr:id><gtr:outcomeId>r-9061043354.739475776fdbe8</gtr:outcomeId><gtr:sectors><gtr:sector>Agriculture, Food and Drink,Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Defined protocols for obtaining samples for metabolome analysis (GC/MS and 1H-NMR-based) of P. aeruginosa.</gtr:description><gtr:id>24E4DD1A-8C60-4908-9D36-D956263DB21A</gtr:id><gtr:impact>We are scripting a paper on this subject as I write (November 2014).</gtr:impact><gtr:outcomeId>r-2861921585.036369ac790b58</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Improved metabolite extraction protocols</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Plasmids that express GFP(ASV)and MCherry in P. aeruginosa for fluorescence microscopy studies.



P. aeruginosa shuttle vectors that express PA0713, PA3572, mmsR and PA5446 from their own promoters in trans.</gtr:description><gtr:id>B00A413B-055D-4F85-8189-D78F8803AC28</gtr:id><gtr:impact>None at the moment - we are still working on this. However, this work did contribute towards the development of collaborative links with a team in Finland (Dr Paivi Tamela, University of Helsinki) who came to visit the lab for 2 months in 2011, and alos partially assisted us in securing EU ITN funding for a student (to begin in 2015).</gtr:impact><gtr:outcomeId>r-1690806524.5401175c6b563ba</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>DNA constructs</gtr:title><gtr:type>Model of mechanisms or symptoms - in vitro</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Strains that carry chromosomally-encoded (mini-CTX derived) insertions reporting on the transcription of P. aeruginosa genes exoS, PA0713, PA0715, PA0717, PA3572, PA0747, mmsAB, mmsR, PA3573, PA3574, PA4735, PA5446, rmd (PA5454), PA5460. These genes are all differentially expressed in biofilm samples, and form part of the &amp;quot;core&amp;quot; biofilm transcriptome. 



Mutant strains of P. aeruginosa carrying insertions in PA0713, PA0747 and PA3572.</gtr:description><gtr:id>23A293A1-F6BF-4C31-8B92-A59109493BEF</gtr:id><gtr:impact>None as yet - the research is ongoing (by an MPhil student).</gtr:impact><gtr:outcomeId>r-8965848096.614563ac78e466</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Bacterial strains</gtr:title><gtr:type>Model of mechanisms or symptoms - in vitro</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>A polyclonal antibody raised against PA2783 - a biofilm-specific secreted P. aeruginosa protein.</gtr:description><gtr:id>6C01F0F3-E0A8-40C2-99DC-0120B5FF0D21</gtr:id><gtr:impact>We are currently testing this antibody to determine whether it might be a useable tool to detect biofilms in clinical samples.</gtr:impact><gtr:outcomeId>r-5166963120.146621c6b2c7b8</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Antibody against a biofilm-specific protein</gtr:title><gtr:type>Antibody</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>9AAB5A47-AA81-4609-9ED7-404A6BD885FE</gtr:id><gtr:title>Kinetic model for signal binding to the Quorum sensing regulator LasR.</gtr:title><gtr:parentPublicationTitle>International journal of molecular sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f7d2e3f01093d945643804e0a2dc3b0"><gtr:id>1f7d2e3f01093d945643804e0a2dc3b0</gtr:id><gtr:otherNames>Claussen A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1422-0067</gtr:issn><gtr:outcomeId>5444ff8abbba73.00244333</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DB908AA3-1F1B-497F-95A9-62D2D08BC350</gtr:id><gtr:title>Comparative microarray analysis reveals that the core biofilm-associated transcriptome of Pseudomonas aeruginosa comprises relatively few genes.</gtr:title><gtr:parentPublicationTitle>Environmental microbiology reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/278f51d88ce352a7595428209fe638a0"><gtr:id>278f51d88ce352a7595428209fe638a0</gtr:id><gtr:otherNames>Patell S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1758-2229</gtr:issn><gtr:outcomeId>doi_53d06b06badb4d96</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3BF88898-D0B3-45DF-8112-CCBD103CFAAE</gtr:id><gtr:title>Mutation of nfxB causes global changes in the physiology and metabolism of Pseudomonas aeruginosa.</gtr:title><gtr:parentPublicationTitle>Journal of proteome research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7d8569a32f9bca8e853d7b121a553469"><gtr:id>7d8569a32f9bca8e853d7b121a553469</gtr:id><gtr:otherNames>Stickland HG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1535-3893</gtr:issn><gtr:outcomeId>doi_53d01c01cc3ec3f5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E00F45DA-860F-480E-8671-2977C3B65819</gtr:id><gtr:title>Mastering the chemical language of bacteria.</gtr:title><gtr:parentPublicationTitle>Chemistry &amp; biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6856374005cbfc4b901c02ec9edfe80c"><gtr:id>6856374005cbfc4b901c02ec9edfe80c</gtr:id><gtr:otherNames>Galloway WR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1074-5521</gtr:issn><gtr:outcomeId>pm_53cbfabbfab039f6e</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>89333650-C1D2-497A-881B-6F431DD6CC0F</gtr:id><gtr:title>Microbial biofilm as a smart material.</gtr:title><gtr:parentPublicationTitle>Sensors (Basel, Switzerland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5913677e5f57ae88eec7515e9a390dae"><gtr:id>5913677e5f57ae88eec7515e9a390dae</gtr:id><gtr:otherNames>Garde C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1424-8220</gtr:issn><gtr:outcomeId>56b235fe968521.09862668</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CA1F3FBC-5F26-474E-9283-3177E6545C8C</gtr:id><gtr:title>Ligand binding kinetics of the quorum sensing regulator PqsR.</gtr:title><gtr:parentPublicationTitle>Biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/025687429ee495ba74fb3b09bc9a7645"><gtr:id>025687429ee495ba74fb3b09bc9a7645</gtr:id><gtr:otherNames>Welch M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-2960</gtr:issn><gtr:outcomeId>5444ff8b146410.34501749</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6BA8C0A6-4B3A-4CA9-A54B-5C46979BD63D</gtr:id><gtr:title>Mep72, a metzincin protease that is preferentially secreted by biofilms of Pseudomonas aeruginosa.</gtr:title><gtr:parentPublicationTitle>Journal of bacteriology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6059856a3acba30c22b02706e4d9e828"><gtr:id>6059856a3acba30c22b02706e4d9e828</gtr:id><gtr:otherNames>Passmore IJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0021-9193</gtr:issn><gtr:outcomeId>56b235fed02a41.46387948</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FE8788EB-3C94-4186-B283-83CF04E6A4D7</gtr:id><gtr:title>Towards quorum-quenching catalytic antibodies.</gtr:title><gtr:parentPublicationTitle>Chemical communications (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3a21040f1d69786785a53e7c8fd75a4d"><gtr:id>3a21040f1d69786785a53e7c8fd75a4d</gtr:id><gtr:otherNames>Kapadnis PB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1359-7345</gtr:issn><gtr:outcomeId>doi_53d02b02b4f854c2</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/F01581X/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>